MAR 15, 2019 12:41 AM PDT

Vaccine Blocks Osteoarthritis Pain in Mice

WRITTEN BY: Nouran Amin

A virus-like particle vaccine was developed to stop chronic pain caused by osteoarthritis inhibiting a nerve growth factor (NGF). The vaccine was administered in mice who exhibited symptoms of painful osteoarthritis and was shown to visibly reverse these effects. The vaccine works by triggering the immune system to produce antibodies to block naturally-occurring NGF. “I’m happy to see the vaccine platform perform so well, and look forward to seeing the vaccine enter clinical testing in companion animals,” said co-lead author Professor Martin Bachmann, from the Jenner Institute at the University of Oxford and the University of Bern.

Pain in osteoarthritis poses a substantial social and economic burden with fewer than 25% of patients having adequate pain control. NGF has emerged as a key driver of pain behavior in murine studies and antibodies to NGF are potent analgesics in human osteoarthritis. Using a novel virus-like particle, von Loga et al created a therapeutic vaccine that reversibly induced antibodies against NGF and abrogated pain behavior in murine osteoarthritis.

Image credit: OpenStax / CC BY 4.0.

“This is the first successful vaccination to target pain in osteoarthritis, one of the biggest healthcare challenges of our generation,” said co-lead author Professor Tonia Vincent, a researcher at the Kennedy Institute of Rheumatology at the University of Oxford.“Whilst there are still safety issues that need to be considered before these types of approaches can be used in patients, we are reassured that this vaccine design allows us to control antibody levels and thus tailor treatment to individual cases according to need.”

Current pain relief therapeutics for osteoarthritis include NSAID’s and opioids. However, NGF is a promising target for osteoarthritis pain.

“Too many people living with pain do not get effective relief from the treatments that are currently available, and that is why the development of more effective painkillers, with fewer side-effects, is vital for people living with arthritis,” said Dr. Stephen Simpson, Director of research at Versus Arthritis, which funded the study. “Although at an early stage, this is highly innovative research and these results are very promising.”

Findings of the study were published in Annals of Rheumatic Disease.

Source: Sci-News

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 11, 2020
Drug Discovery & Development
Novel Therapeutic for ALS
SEP 11, 2020
Novel Therapeutic for ALS
The TDP-43 protein is a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). A ...
SEP 20, 2020
Drug Discovery & Development
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
SEP 20, 2020
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
Almost a year into the beginnings of the COVID-19 pandemic and we still do not have a Food and Drug Administration (FDA) ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
OCT 21, 2020
Microbiology
The First Treatment for Ebola is Approved by FDA
OCT 21, 2020
The First Treatment for Ebola is Approved by FDA
Ebola virus can pass from animals to humans, and between people. Rarely, it causes outbreaks but when it does, they can ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
Loading Comments...